Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Surabhi Parashar"'
Autor:
Surabhi Parashar, David Cheishvili, Niaz Mahmood, Ani Arakelian, Imrana Tanvir, Haseeb Ahmed Khan, Richard Kremer, Catalin Mihalcioiu, Moshe Szyf, Shafaat A. Rabbani
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Immune surveillance acts as a defense mechanism in cancer, and its disruption is involved in cancer progression. DNA methylation reflects the phenotypic identity of cells and recent data suggested that DNA methylation profiles of
Externí odkaz:
https://doaj.org/article/04072641a1564a9793a9c8b976a62e1b
Autor:
Shafaat A. Rabbani, Ani Arakelian, Imrana Tanvir, Surabhi Parashar, Niaz Mahmood, Moshe Szyf, David Cheishvili, Haseeb Ahmed Khan, Richard Kremer, Catalin Mihalcioiu
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
BMC Cancer
BMC Cancer
Background Prostate Cancer (PCa) is the second most common cancer in men where advancements have been made for early detection using imaging techniques, however these are limited by lesion size. Immune surveillance has emerged as an effective approac
Autor:
David Cheishvili, Ani Arakelian, Niaz Mahmood, Surabhi Parashar, David Goltzman, Moshe Szyf, Richard Kremer, Shafaat A. Rabbani
Publikováno v:
Journal of Bone and Mineral Research. 36:2285-2286
Osteoporosis is one of the most common age-related progressive bone diseases in elderly people. Approximately one in three women and one in five men are predisposed to developing osteoporosis. In postmenopausal women, a reduction in BMD leads to an i
Autor:
Flora Chik, Shafaat A. Rabbani, Moshe Szyf, Ani Arakelian, Surabhi Parashar, Nicholas Shukeir, Barbara Stefanska
Publikováno v:
British Journal of Pharmacology. 172:2769-2781
Background and Purpose DNA hypomethylation was previously implicated in metastasis. In the present study, we examined whether methyl supplementation with the universal methyl donor S-adenosylmethionine (SAM) inhibits prostate cancer associated skelet